Octadecanoic acid, zinc salt
CAS 557-05-1
Octadecanoic acid, zinc salt (CAS 557-05-1) is a pharmaceutical compound with 0 bioactivity targets and 4 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Octadecanoic acid, zinc salt is linked to DTXSID7027209 in DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Octadecanoic acid, zinc salt used for in pharmaceutical contexts?
Octadecanoic acid, zinc salt (CAS 557-05-1) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Octadecanoic acid, zinc salt?
Octadecanoic acid, zinc salt has 4 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Accidental exposure to product, Dacryostenosis acquired, Eye irritation, Intentional product use issue. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Octadecanoic acid, zinc salt also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Zinc Stearate with EU status "permitted".
What clinical phase is Octadecanoic acid, zinc salt in?
No phase 1-4 clinical development badge is rendered for Octadecanoic acid, zinc salt because the matched compound identifier rows do not contain a max-phase value.